← Holders
5AM Venture Management, LLC
What 5AM Venture Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1799883 · Filed Nov 16, 2026
- Positions
- 16
- Reported value
- $297M
- Opened
- 2
- Closed
- 2
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$273M25 positions
- Dec 31, 2025$318.1M21 positions
- Mar 31, 2026$360.2M20 positions
- Jun 30, 2026$287.9M16 positions
- Sep 30, 2026$297M16 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
LTGOLatigo Biotherapeutics, Inc. | 7.3M | New | $122.3M | 41.2% |
TRDAEntrada Therapeutics, Inc. | 3.8M | −6.7% | $24M | 8.1% |
TYRATyra Biosciences, Inc. | 1M | ±0% | $22.5M | 7.6% |
CAMPCamp4 Therapeutics Corp | 5.3M | −10.1% | $21.3M | 7.2% |
ARTVArtiva Biotherapeutics, Inc. | 2.4M | ±0% | $16.8M | 5.6% |
PHVSPharvaris N.V. | 479.9K | −39.8% | $15.2M | 5.1% |
TECXTectonic Therapeutic, Inc. | 606.7K | ±0% | $14.1M | 4.8% |
CLDXCelldex Therapeutics, Inc. | 422.3K | −15.1% | $13.7M | 4.6% |
ZNTLZentalis Pharmaceuticals, Inc. | 3.9M | ±0% | $10.9M | 3.7% |
BHVNBiohaven Ltd. | 739K | ±0% | $9.9M | 3.3% |
MPLTMapLight Therapeutics, Inc. | 741.9K | −21.9% | $7.6M | 2.5% |
SLNSilence Therapeutics plc | 476.2K | ±0% | $5.2M | 1.8% |
ALXOALX Oncology Holdings Inc | 3.1M | ±0% | $4.2M | 1.4% |
TARAProtara Therapeutics, Inc. | 1.4M | ±0% | $4.2M | 1.4% |
EYPTEyePoint, Inc. | 1.1M | ±0% | $3.4M | 1.2% |
SKYESkye Bioscience, Inc. | 981.3K | New | $1.6M | 0.5% |